Last updated on June 2019

Open Label Study to Evaluate Safety Tolerability and Efficacy of Evolocumab (AMG 145) in Pediatric Subjects (10 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia (HeFH) or Homozygous Familial Hypercholesterolemia (HoFH).


Brief description of study

To describe the safety and tolerability of 80 weeks of subcutaneous (SC) evolocumab (AMG 145) when added to standard of care in pediatric subjects 10 to 17 years of age with HeFH or HoFH.

Detailed Study Description

An open label, single arm study to evaluate the safety and tolerability of 80 weeks of SC evolocumab when added to standard of care in pediatric subjects 10 to 17 years of age with HeFH or HoFH.

Clinical Study Identifier: NCT02624869

Find a site near you

Start Over

Research Site

Bronx, NY United States
  Connect »

Research Site

Cincinnati, OH United States
  Connect »

Research Site

Nashville, TN United States
  Connect »

Research Site

Camperdown, Australia
  Connect »

Research Site

Feldkirch, Austria
  Connect »

Research Site

Salzburg, Austria
  Connect »

Research Site

La Louvière, Belgium
  Connect »

Research Site

Fortaleza, Brazil
  Connect »

Research Site

Brasília, Brazil
  Connect »

Research Site

São Paulo, Brazil
  Connect »

Research Site

Chicoutimi, QC Canada
  Connect »

Research Site

Quebec, QC Canada
  Connect »

Research Site

Barranquilla, Colombia
  Connect »

Research Site

Svitavy, Czechia
  Connect »

Research Site

Thessaloniki, Greece
  Connect »

Research Site

Budapest, Hungary
  Connect »

Research Site

Amsterdam, Netherlands
  Connect »

Research Site

Parktown, South Africa
  Connect »

Research Site

Parow, South Africa
  Connect »

Research Site

A Coruña, Spain
  Connect »

Research Site

Geneva 14, Switzerland
  Connect »

Research Site

Reinach, Switzerland
  Connect »

Research Site

Birmingham, United Kingdom
  Connect »

Research Site

La Louvière, Belgium
  Connect »

Research Site

Brasília, Brazil
  Connect »

Research Site

São Paulo, Brazil
  Connect »

Research Site

A Coruña, Spain
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.